Narrator: This is Science Today. A recent study found that Chinese medicine, in combination with standard therapy, greatly enhanced the treatment of patients with Hepatitis B. Now, researchers led by Michael McCulloch, a doctoral student in epidemiology at the University of California, Berkeley's School of Public Health, are planning to conduct another study to see if Chinese herbs also benefit patients with breast and lung cancer.
McCulloch: We're going to do a similar kind of research question. Does adding herbal medicine to chemotherapy enhance the treatment outcomes for people with breast cancer and lung cancer?
Narrator: McCulloch, who is also a licensed acupuncturist, has been working with Chinese herbs for two decades.
McCulloch: Our clinical experience has been that people using Chinese medicine in conjunction with conventional care experience lower side effects going through treatment and better long-term treatment outcomes. We're hoping to demonstrate that in our next meta-analysis project.
Narrator: McCulloch hopes their studies will result in an open dialogue between Eastern and Western medicine. For Science Today, I'm Larissa Branin.